secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-08-14T12:00:39+00:00
Accession:  0001140361-26-032947
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech shareholders approve doubling authorized shares to 300M; reelect two directors
--------------------------------------------------------------------------------

- Shareholders approved amendment increasing authorized common stock from 150M to 300M shares (19.9M for, 11.5M against).
- Kamil Ali-Jackson and Ilian Iliev elected as Class B directors; each received ~9M votes for.
- KPMG US LLP ratified as independent auditor for FY2026 (30.4M for).
- Non-binding say-on-pay approved (7.2M for, 4.0M against, 19.3M broker non-votes).
- Quorum of 56.6% (31.6M of 55.8M shares) represented at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126032947/0001140361-26-032947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126032947/ef20080184_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-032947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer